USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 404 Shares

USANA Health Sciences, Inc. (NYSE:USNAGet Rating) Director Gilbert A. Fuller sold 404 shares of the firm’s stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $70.00, for a total transaction of $28,280.00. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Gilbert A. Fuller also recently made the following trade(s):

  • On Friday, May 20th, Gilbert A. Fuller sold 312 shares of USANA Health Sciences stock. The stock was sold at an average price of $68.25, for a total transaction of $21,294.00.

USANA Health Sciences Trading Up 0.5 %

Shares of USNA stock opened at $69.96 on Tuesday. The firm has a 50-day moving average price of $70.84 and a 200 day moving average price of $78.99. USANA Health Sciences, Inc. has a twelve month low of $63.49 and a twelve month high of $103.95. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of 15.41 and a beta of 0.72.

USANA Health Sciences (NYSE:USNAGet Rating) last announced its earnings results on Tuesday, July 26th. The company reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.05 by ($0.05). USANA Health Sciences had a net margin of 8.27% and a return on equity of 22.49%. During the same quarter last year, the company posted $1.87 earnings per share. As a group, research analysts predict that USANA Health Sciences, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on USNA shares. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Tuesday, April 26th. Jefferies Financial Group lowered shares of USANA Health Sciences from a “hold” rating to an “underperform” rating and lowered their price objective for the company from $78.00 to $53.00 in a research report on Thursday, July 7th. Finally, DA Davidson restated a “maintains” rating on shares of USANA Health Sciences in a research report on Thursday, July 28th. One research analyst has rated the stock with a sell rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $77.33.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of USNA. Allspring Global Investments Holdings LLC acquired a new position in shares of USANA Health Sciences during the 4th quarter valued at about $5,503,000. Meritage Portfolio Management acquired a new position in shares of USANA Health Sciences during the 4th quarter valued at about $229,000. Yousif Capital Management LLC acquired a new position in shares of USANA Health Sciences during the 4th quarter valued at about $1,071,000. CWM LLC acquired a new position in shares of USANA Health Sciences during the 4th quarter valued at about $71,000. Finally, Qube Research & Technologies Ltd increased its stake in shares of USANA Health Sciences by 162.3% during the 4th quarter. Qube Research & Technologies Ltd now owns 6,120 shares of the company’s stock valued at $619,000 after acquiring an additional 3,787 shares during the last quarter. Institutional investors and hedge funds own 55.72% of the company’s stock.

About USANA Health Sciences

(Get Rating)

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products.

Further Reading

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Want More Great Investing Ideas?

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.